BRCA2 and ovarian serous adenocarcinoma: Several studies in serous ovarian cancer highlight the prognostic and predictive roles of BRCA1 and BRCA2 germlines and somatic mutations in survival and responses to platinum-based treatments [28,29,30,31,32,33,34].